Lifileucel (LN-144)
22-322
Phase 1 mab active
Quick answer
Lifileucel (LN-144) for Metastatic Melanoma is a Phase 1 program (mab) at Iovance Biotherapeutics B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Iovance Biotherapeutics B.V.
- Indication
- Metastatic Melanoma
- Phase
- Phase 1
- Modality
- mab
- Status
- active